Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 9324310, 8 pages
https://doi.org/10.1155/2017/9324310
Clinical Study

Renal Function Improvement by Telbivudine in Liver Transplant Recipients with Chronic Kidney Disease

1Department of Liver and Transplantation Surgery, Chang-Gung Memorial Hospital, Chang-Gung University College of Medicine, Taoyuan, Taiwan
2Department of Hepatology, Chang-Gung Memorial Hospital, Chang-Gung University College of Medicine, Taoyuan, Taiwan

Correspondence should be addressed to Wei-Chen Lee; wt.gro.hmgc@nehciew

Received 22 March 2017; Revised 29 June 2017; Accepted 9 July 2017; Published 13 August 2017

Academic Editor: Fumio Imazeki

Copyright © 2017 Wei-Chen Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Mazzaferro, E. Regalia, R. Doci et al., “Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis,” The New England Journal of Medicine, vol. 334, no. 11, pp. 693–699, 1996. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Bernardi, S. Gitto, and M. Biselli, “The MELD score in patients awaiting liver transplant: strengths and weaknesses,” Journal of Hepatology, vol. 54, no. 6, pp. 1297–1306, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Malinchoc, P. S. Kamath, F. D. Gordon, C. J. Peine, J. Rank, and P. C. J. Ter Borg, “A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts,” Hepatology, vol. 31, no. 4, pp. 864–871, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. D. B. Kaufman, R. Shapiro, M. R. Lucey, W. S. Cherikh, R. T. Bustami, and D. B. Dyke, “Immunosuppression: practice and trends,” The American Journal of Transplantation, vol. 4, supplement 9, pp. 38–53, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. A. A. Pillai and J. Levitsky, “Overview of immunosuppression in liver transplantation,” World Journal of Gastroenterology, vol. 15, no. 34, pp. 4225–4233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Duvoux and G. P. Pageaux, “Immunosuppression in liver transplant recipients with renal impairment,” Journal of Hepatology, vol. 54, no. 5, pp. 1041–1054, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. A. O. Ojo, P. J. Held, F. K. Port et al., “Chronic renal failure after transplantation of a nonrenal organ,” The New England Journal of Medicine, vol. 349, no. 10, pp. 931–940, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Manne, R. M. Allen, and S. Saab, “Strategies for the prevention of recurrent hepatitis B virus infection after liver transplantation,” Gastroenterology & Hepatology, vol. 10, pp. 175–179, 2014. View at Google Scholar
  9. E. J. Gane, P. W. Angus, S. Strasser et al., “Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation,” Gastroenterology, vol. 132, no. 3, pp. 931–937, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Loomba, A. K. Rowley, R. Wesley et al., “Hepatitis B immunoglobulin and lamivudine improve hepatitis B-related outcomes after liver transplantation: meta-analysis,” Clinical Gastroenterology and Hepatology, vol. 6, no. 6, pp. 696–700, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. E. J. Gane, G. Deray, Y.-F. Liaw et al., “Telbivudine improves renal function in patients with chronic hepatitis B,” Gastroenterology, vol. 146, no. 1, pp. 138e5–146e5, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Wang, S. Thongsawat, E. J. Gane et al., “Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B,” Journal of Viral Hepatitis, vol. 20, no. 4, pp. e37–e46, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. A. S. Levey, K. U. Eckardt, Y. Tsukamoto et al., “Definition and classification of chronic kidney disease: a position statement from Kidney Disease: improving global outcomes (KDIGO),” Kidney International, vol. 67, no. 6, pp. 2089–2100, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Pawarode, D. M. Fine, and P. J. Thuluvath, “Independent risk factors and natural history of renal dysfunction in liver transplant recipients,” Liver Transplantation, vol. 9, no. 7, pp. 741–747, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. C.-S. Wong, W.-C. Lee, C.-C. Jenq et al., “Scoring short-term mortality after liver transplantation,” Liver Transplantation, vol. 16, no. 2, pp. 138–146, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. C. J. Dunn, A. J. Wagstaff, C. M. Perry, G. L. Plosker, and K. L. Goa, “Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation,” Drugs, vol. 61, no. 13, pp. 1957–2016, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. L. J. Scott, K. McKeage, S. J. Keam, and G. L. Plosker, “Tacrolimus: a further update of its use in the management of organ transplantation,” Drugs, vol. 63, no. 12, pp. 1247–1297, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Cárdenas and P. Ginès, “Acute-on-chronic liver failure: the kidneys,” Current Opinion in Critical Care, vol. 17, no. 2, pp. 184–189, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Crespo, Z. Mario, M. Navasa, and X. Forns, “Viral hepatitis in liver transplantation,” Gastroenterology, vol. 142, no. 6, pp. 1373e1–1383e1, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Qi, J.-Y. Wang, R.-C. Mao, and J.-M. Zhang, “Impact of nucleos(t)ide analogues on the estimated glomerular filtration rate in patients with Chronic hepatitis B: a prospective cohort study in China,” Journal of Viral Hepatitis, vol. 22, no. 1, pp. 46–54, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Perrella, A. G. Lanza, D. Pisaniello, G. Dicostanzo, F. Calise, and O. Cuomo, “Telbivudine prophylaxis for hepatitis B virus recurrence after liver transplantation improves renal function,” Transplantation Proceedings, vol. 46, no. 7, pp. 2319–2321, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Cholongitas, T. Vasiliadis, I. Goulis et al., “Telbivudine is associated with improvement of renal function in patients transplanted for HBV liver disease,” Journal of Viral Hepatitis, vol. 22, no. 7, pp. 574–580, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. I. Turan, S. Yapali, F. Bademkiran et al., “Telbivudine in liver transplant recipients: renal protection does not overcome the risk of polyneuropathy and myopathy,” Liver Transplantation, vol. 21, no. 8, pp. 1066–1075, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. C.-L. Lin, R.-N. Chien, C. Yeh et al., “Significant renoprotective effect of telbivudine during preemptive antiviral therapy in advanced liver cancer patients receiving cisplatin-based chemotherapy: a case-control study,” Scandinavian Journal of Gastroenterology, vol. 49, no. 12, pp. 1456–1464, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Liang, Y. Chen, C. Hsu, M. Chang, and C. Yeh, “Decrease of serum angiotensin converting enzyme levels upon telbivudine treatment for chronic hepatitis B virus infection and negative correlations between the enzyme levels and estimated glumerular filtration rates,” Hepatitis Monthly, vol. 14, no. 1, 2014. View at Publisher · View at Google Scholar
  26. M. Lee, S. Oh, H. J. Lee et al., “Telbivudine protects renal function in patients with chronic hepatitis B infection in conjunction with adefovir-based combination therapy,” Journal of Viral Hepatitis, vol. 21, no. 12, pp. 873–881, 2014. View at Publisher · View at Google Scholar · View at Scopus